While pharmaceutical companies and medical device firms know that working together is a vital part of doing business, they “live in 2 different world in many ways,” Minnetronix co-founder Dirk Smith said last week at the annual Drug Delivery Partnerships conference.
From development timelines to regulatory approval pathways, it can sometimes seem like pharma and medtech companies are speaking different languages.
Get the full story at our sister site, Drug Delivery Business News.
The post Early collaboration is key in drug-device development, experts say appeared first on MassDevice.